Humacyte
(NASDAQ) HUMA
Humacyte Financials at a Glance
Market Cap
$142.63M
Revenue (TTM)
$2.04M
Net Income (TTM)
$40.83M
EPS (TTM)
$-0.21
P/E Ratio
-3.11
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$0.65
Volume
4,820,077.109
Open
$0.58
Price
$0.65
Volume
4,820,077.109
Open
$0.58
Previous Close
$0.64
Daily Range
$0.57 - $0.66
52-Week Range
$0.55 - $2.93
Dividend
$0.00
Beta (Volatility)
1.62 (High)
Price
$0.65
Volume
4,820,077.109
Open
$0.58
Previous Close
$0.64
Daily Range
$0.57 - $0.66
52-Week Range
$0.55 - $2.93
HUMA News
HUMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Humacyte
Industry
Biotechnology
Sector
Health CareEmployees
184
CEO
Laura E. Niklason, MD, PhD
Website
humacyte.comHeadquarters
Durham, NC 27713, US
HUMA Financials
Key Financial Metrics (TTM)
Gross Margin
-7%
Operating Margin
-53%
Net Income Margin
-20%
Return on Equity
-257%
Return on Capital
-1%
Return on Assets
-35%
Earnings Yield
-32.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$142.63M
Shares Outstanding
222.02M
Volume
4.82M
Short Interest
0.00%
Avg. Volume
6.94M
Financials (TTM)
Gross Profit
$15.01M
Operating Income
$107.44M
EBITDA
$100.09M
Operating Cash Flow
$105.04M
Capital Expenditure
$884.00K
Free Cash Flow
$105.93M
Cash & ST Invst.
$50.50M
Total Debt
$64.85M
Humacyte Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$467.00K
-93.5%
Gross Profit
$12.27M
-439.5%
Gross Margin
-26.27%
N/A
Market Cap
$142.63M
N/A
Market Cap/Employee
$654.24K
N/A
Employees
218
N/A
Net Income
$24.80M
-18.5%
EBITDA
$97.78M
-488.2%
Quarterly Fundamentals
Net Cash
$14.35M
-150.5%
Accounts Receivable
$441.00K
N/A
Inventory
$13.59M
N/A
Long Term Debt
$62.42M
+358.3%
Short Term Debt
$2.43M
-16.8%
Return on Assets
-35.09%
N/A
Return on Invested Capital
-1.10%
N/A
Free Cash Flow
$26.16M
+1.8%
Operating Cash Flow
$26.12M
+1.7%